TrialPloS one2014

Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial.

Uzma N Sarwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.